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Título: Inventario de fobia a la sangre (BIPI): Desarrollo, fiabilidad y 
validez. 
Resumen: El objetivo de este trabajo es construir el Inventario de Fobia a 
la Sangre-Inyecciones (BIPI) y determinar la fiabilidad y validez de un 
instrumento para medir la ansiedad y fobia a la sangre, adaptado a la po-
blación española. El BIPI recoge las propiedades psicométricas en 174 
participantes. Es un inventario compuesto de 18 situaciones o estímulos 
relacionados con la sangre y 27 síntomas fóbicos, valorados en una escala 
de Likert con cuatro opciones de respuesta. El coeficiente alfa de Cron-
bach es .98 y posee una buena validez concurrente, convergente y discri-
minante. El análisis factorial identifica un factor significativo, lo que sugie-
re que la fobia a la sangre es un constructo unitario. Los resultados revelan 
que el BIPI posee unas medidas psicométricas adecuadas y es un instru-
mento válido y fiable para evaluar la fobia a la sangre en población españo-
la. 
Palabras clave: Ansiedad a la sangre; construcción, validación; Inventario 
de Fobia a la Sangre; población española; estudio instrumental. 
 Abstract: The aim of this study was to develop the Blood-Injection 
Phobia Inventory (BIPI) and thus provide a valid and reliable assessment 
instrument for measuring blood anxiety and blood phobia in Spanish 
population. This study examined the psychometric properties of the BIPI 
in 174 Spanish-speaking subjects. The BIPI is a self-administered 
questionnaire of 18 items or stimulus content and 27 phobic responses 
that can be used on a 4-point Likert-type format. The scale had a 
Cronbach’s alpha of .98 and showed good concurrent, convergent, and 
discriminant validity. Factor analysis of the BIPI identified one significant 
factor, suggesting that blood phobia is a unitary psychometric construct. 
This factor explained 76% of stimulus content and 74% of phobic 
responses of the total variance. Results of this study suggest that the BIPI 
has adequate psychometric properties that make it a valid and reliable 
instrument to assess blood phobia in Spanish-speaking individuals. 
Key words: Blood anxiety; construction, validation; Blood-Injection 
Phobia Inventory; Spanish-speaking subjects; instrumental study. 
 
Introduction 
 
Over the last decades, research on treatment efficacy of the 
approach of specific phobias has undergone an interesting 
development (Choy, Fyer, & Lipsitz, 2007). All the con-
trolled studies with in vivo exposure in the treatment of peo-
ple with phobias have shown that it is effective to reduce 
subjective anxiety and avoidance behaviors in phobics (Öst, 
Alm, Branderg, & Breitholtz, 2001; Walder, McCracken, 
Herbert, James, & Brewitt, 1987; Williams, Dooseman, & 
Kleinfield, 1984). 
 Cognitive factors are considered an important compo-
nent of anxiety. Phobic beliefs, such as an irrational fear of 
the possible danger of the stimuli, play an important role in 
specific phobias (Thorpe & Salkovskis, 1995), but only re-
cently has been acknowledged the cognitive therapy as a 
treatment modality. There are no follow-up studies of cogni-
tive therapy in blood phobia. 
 In parallel to the study of the different treatment modali-
ties of blood phobia, diverse assessment measurements have 
been designed. A review of the literature shows that there 
are various types, depending on the characteristics of the 
instruments. The first questionnaires elaborated in the 1960-
70s are general and measure a limited number of contexts 
associated with fears and phobias. For example, the Fear 
Survey Schedule FSS-III (Wolpe & Lang, 1964, 1977) as-
sesses distress in 72 different phobic situations (being alone, 
automobiles, injuries, diseases, birds, etc.). The Fear Ques-
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tionnaire (FQ; Marks &Mathews, 1979) assesses avoidance 
in 15 situations (agoraphobia, social anxiety, and blood pho-
bia), the degree of concern and difficulty produced in the 
person’s life.  
 Since the 1970s, specific instruments were developed to 
identify situations related to blood phobia, for example, in-
jections, injuries, or medical or dental examinations. The 
Mutilation Questionnaire (MQ; Klorman, Weerts, Hastings, 
Melamed, & Lang, 1974) is a 30-item true/false scale that 
assesses the cognitive component when facing stimuli re-
lated to injuries, cuts, deformities, organs, or mutilations. 
The Medical Fear Survey (MFS; Kleinknecht, 1991), from 
the decade of the 1990s, has 70 items and measures the de-
gree of fear in situations related to fear of medical aspects, 
for example, blood, hypodermic needles, or physical symp-
toms. The Medical Avoidance Survey (MAS; Kleincknecht, 
Thorndike, & Walls, 1996) is made up of 21 items and evalu-
ates the avoidance of treatments or the anticipation of the 
consequences. The Blood-Injection Symptom Scale (BISS; 
Page, Bennet, Carter, Smith, & Woodmore, 1997) has 17 
items and measures the presence of physical symptoms 
when facing situations involving blood or injections. Al-
though the MQ, the MFS, the MAS, and the BISS show 
more specificity than the FQ and the FSS-III, the main limi-
tation of these instruments is only assess blood phobic’s 
some situations. 
 Recently, the Multidimensional Blood/Injury Phobia 
Inventory (MBPI; Wenzel & Holt, 2003) was designed. It 
comprises 40 items and assesses in four types of stimuli (in-
jections, hospitals, blood, and injuries) the presence/absence 
of five types of coping responses (fear, avoidance, worry, 
distress, and fainting), with both a self versus other focus. 
This instrument has good psychometric properties and char-
acterizes the totally of blood phobia. 
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 Although there are several measurements to assess 
blood/injection phobia, no instrument adapted to the Span-
ish population with similar characteristics as the MBPI has 
been designed. The Blood-Injection Phobia Inventory 
(BIPI) comprises 18 situations involving blood and injec-
tions. It assesses in vivo anxiety and anticipatory anxiety in 
three types of responses (cognitive, physiological, and be-
havioral), with the phobic stimulus affecting either oneself 
or other persons.  
 This instrumental study (Carretero-Dios & Pérez, 2007) 
has three goals. In the first time, we explored the psycho-
metric characteristics of the BIPI. For reliability we used 
Cronbach’s alpha coefficient and for convergent validity we 
used Pearson’s correlation coefficient, both from BIPI. The 
discriminant validity was obtained from the same correlation 
coefficient, using the FQ and the BIPI. 
We used a sample from the general population to exam-
ine whether this instrument discriminates between people 
diagnosed with blood-injection-injury phobia (according to 
the Diagnostic and Statistical Manual of Mental Disorders, 4th edi-
tion (American Psychiatric Association, 1994) from people 
without this phobia. In the second time, we determined 
whether blood phobia is a one-dimensional construct. We 
included stimuli related to different specific phobias (inju-
ries, injections, and medical interventions) and different 
types of responses (cognitive, physiological, and behavioral). 
In the third time, we examined whether the BIPI is a sensi-
tive instrument to evaluate the therapeutic change in people 
diagnosed with blood-injection-injury phobia according to 
the DSM-IV (APA, 1994). For all participants, treatment 
consisted of six group sessions of exposure in vivo. One of 
the two groups was treated with applied tension (exposure in 
vivo + tension technique). 
 
Method 
 
Participants 
 
The sample was made up of two groups of participants: 
(a) a clinical sample comprising 39 patients, 30 female 
(77.5%), diagnosed with specific phobia, blood-injection-
injury type, according to the criteria of the DSM-IV (APA, 
1994), by means of the Structured Clinical Interview for 
DSM-III-R (SCID, Spitzer & Williams, 1987) and not af-
fected by any other kind of phobia or anxiety disorder, aged 
between 15 and 30 years (M = 23.73, SD = 3.49). Partici-
pants completed the Fear Questionnaire (Marks & Mathews, 
1979) (M FQ-Blood/Injection = 20.26, SD = 8.96). Of the 
sample, 82.5% were married and 64.15% had a degree or 
higher education; (b) a normal sample of 135 people selected 
from the population, 67 male (49.6%) and 68 female 
(50.4%), aged between 15 and 30 years (M = 22.87 years, SD 
= 3.87). Of the sample, 73.6% were married and 94.23% had 
degree or higher education. This sample was paired with the 
patients in the variables age and gender. There were no sig-
nificant differences in age, marital status or education level. 
All the participants were from the Region of Andalusia 
(Spain). 
 In order to determine the characteristics of blood phobia 
in the clinical sample, we elaborated an interview with spe-
cific information: gender, age, age at onset disorder and 
presence of family history (yes/no). Furthermore, it was 
assessed on a scale with five response options the interfer-
ence of blood phobia at the time of interview: the presence 
of episodes of fainting (from never to always), the perceived 
ability/capacity to control the problem (from nothing at all) 
the degree of disability in everyday life (from nothing to 
total). Finally, information was obtained about past and pre-
sent medical, psychological and psychopharmacological 
treatments received because of any mental disorder, espe-
cially related to blood phobia, or health-related complica-
tion. 
In 72.1%, the problem had appeared in childhood, and 
in 46%, there were direct family antecedents with blood-
injury phobia. Regarding the degree of impairment or inter-
ference in daily life, a notably high percentage (86.1%) re-
ported that the phobia caused them pretty much/a lot of im-
pairment. Moreover, 70.8% of the clinical sample reported 
having low capacity of self-control. And in almost one half 
of the blood phobics, fainting behavior was present, with a 
frequency of sometimes/almost always.  
 People who, after medical examination, presented certain 
medical complications (i.e., coronary problems or neurologi-
cal injuries) and people who reported having suffered or 
suffering some psychopathological disorder —except for 
blood phobia— and/or who were receiving psychopharma-
logical or psychological treatment were excluded from the 
study. 
 
Assessment Instruments 
 
Fear Questionnaire (FQ) (Marks & Mathews, 1979).- This is a 
self-report designed to measure agoraphobic fear, social 
anxiety, and blood-injection-injury type phobia. The first 
part has 15 items that measure the degree to which the per-
son avoids each situation on a 9-point Likert scale, ranging 
from 0 (I don’t avoid it) to 8 (I always avoid it). The subscale of 
blood/injury phobia is made up of 5 items about blood 
and/or injuries (range: 0 - 40 points). The second part of the 
questionnaire allows subjects to appraise the concern caused 
by certain symptoms or thoughts and the current state of 
their phobic symptoms, anxiety and depression conjointly as 
well as the global appraisal of the impairment produced by 
the phobia.  
 The first part of the FQ has been shown to have high 
internal consistency, as well as being a reliable and valid 
measurement to discriminate agoraphobia from social pho-
bia (Cox, Swinson, & Shaw, 1991). In the Spanish adaptation 
(Sandín, Valiente, & Chorot, 1999), the internal consistency 
alpha coefficients of this questionnaire were: .78 (FQ total), 
.75 (blood-injections-injuries), .64 (social anxiety) and .55 
(agoraphobia). 
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 This instrument has good test-retest reliability (r = .96 
for blood phobia and physical injuries). The subscale of 
blood phobia has been used as a measure of convergent 
validity and the subscales of social anxiety and agoraphobic 
fear as a measure of discriminant validity. 
 
Blood-Injection Phobia Inventory (BIPI).- This was specifically 
designed to assess fear of blood. In its preliminary version 
(See Appendix I), it had 50 items about diverse situations 
preferably related to blood, injections, and the dentist (32 
situations) and, to a lesser degree, animal blood (5 situations) 
and the color red (4 situations) to check whether produce 
similar phobic symptoms, agoraphobia (5 situations), and 
social anxiety (4 situations). It measures the frequency of 
symptoms on a 4-point scale ranging from 0 (never) to 3 (al-
ways), of the patient’s different types of responses (cognitive, 
physiological, and behavioral), and also appraises both “situ-
ational anxiety” and “anticipatory anxiety” responses (see 
Appendix 1). It developed from a review of the literature of 
the subject and the clinical experience of researchers. The 
proposed version in this paper is showed in the Appendix 2. 
 
Procedure  
 
The clinical sample was obtained by means of the mass 
media (radio and press). In the information provided, we 
alluded to the research being carried out from the University 
and the possibility of participating in the study by receiving 
free psychological treatment. Likewise, we specified the 
problem, its characteristics, the goals we hoped to achieve, 
and we included a contact phone number. After the tele-
phone conversation, we scheduled the first appointment for 
an individual interview. In the interview, we collected the 
personal data, the person’s history, etc. Subsequently, in a 
second session, we proceeded with the assessment and the 
diagnosis, according to the criteria of the DSM-IV (APA, 
1994) of specific phobia, subtype blood-injections-injuries. 
Before beginning the assessment of the participants, we pro-
vided information about the investigation, we clarified all 
their doubts, and they provided written informed consent. 
They were informed that their participation was voluntary 
and they could leave the study whenever they wanted to 
without having to offer any explanations. 
To obtain the sample population, we requested the col-
laboration of the associates and colleagues of the research 
team who had some knowledge of psychology studies (sec-
ond-cycle students and/or postgraduates). They were re-
sponsible for recruiting people between 15 and 30 years. We 
used the criterion of contact with nine people in the general 
population of the same age and sex for each participant, so 
that the composition in terms of these variables were similar 
for both samples. Recovering rate of self reports was 54%. 
They were informed about the goal of the investigation, 
the aim of the use of the inventory and, particularly, about 
the procedure to evaluate the test (response options, situa-
tions it comprised, and symptomatology in the triple re-
sponse system). Along with this information and after sign-
ing the Informed Consent, they were given a series of con-
crete instructions (i.e., self-application) to homogenize the 
procedure to be followed and to ensure the rigor of the in-
vestigation as much as possible. 
 Each instrument was identified with a code, the age, and 
gender, as well as other descriptive data (studies/profession, 
place or residence, etc.), the same characteristics as those to 
be considered in the clinical sample. 
 
Construction of the Blood-Injection Phobia Inven-
tory (BIPI) 
 
a) Situations 
 
Descriptive statistic characteristics.- The first criterion used to 
select the situations was that they had to discriminate statis-
tically between the normal group and the phobic group. Of 
the 50 situations included initially, only 40 provided statisti-
cally different means (p < .05) between the groups. We 
eliminated the following items: the agoraphobic situations 1, 
28, 46, and 50; the situations related to social anxiety 3 and 
43; three of the four situations that referred to the color red 
(situations 10, 16, and 27), and one situation (number 17) of 
the five that referred to animal blood (see Table 1). 
 
b) Symptoms 
 
Descriptive statistic characteristics.- To determine the power of 
discrimination of each of the symptoms of the three types of 
response, as the first criterion, we proceeded to compare the 
mean scores of both groups. Out of 32 symptoms, 31 dis-
criminated; in contrast, 1 of the 12 cognitive responses (L 
symptoms “I think I’m going mad”) did not yield any differ-
ences between the normal sample and the blood phobics 
(see Table 2). 
 
Results 
 
Exploratory factor analysis of the situations of the 
BIPI 
 
Exploratory factor analysis with principal components 
and varimax rotation was applied to the 40 situations result-
ing from applying the above-mentioned criterion. We used 
Kaiser’s criterion (eigenvalues higher than 1) to retain fac-
tors and we selected only the items with loadings over .50 
(see Table 3). Using this criterion, we eliminated another 
four situations: 11, 14, 24, and 44. 
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Table 1: Situations that discriminate between the normal and the blood phobic sample (N = 174). 
Normal 
(n = 135) 
Blood  
phobics  
(n = 39) 
Situations 
(rank: 0-96) 
M SD M SD 
Value of  
Contrast 
Statistic 
 
p 
 1. When I walk along the beach or in the mountains. 2.98 5.71 1.97 3.52 1.350 .180
 2. When I see an injured person after an accident, bleeding in the road or on TV.  8.86 8.89 25.46 20.79 -4.755 <.001
 3. In a group of friends or coworkers, when they ask my opinion. 3.84 5.99 6.26 8.42 -1.693 .097
 4. When going to the dentist for a check-up. 6.02 7.63 22.46 23.83 -4.058 <.001
 5. When I see blood on my arm or finger after pricking myself with a needle. 3.64 6.42 29.61 21.66 -6.996 <.001
 6. When I feel discomfort in my mouth and think about having to go to the dentist, without consid-
ering the possibility of pain.  
2.17 4.13 14.51 18.01 -4.100 <.001
 7. When I get an intravenous injection. 7.02 8.91 41.64 24.96 -8.055 <.001
 8. If I’m in the kitchen and I see a knife with blood on it after cutting meat.  .72 2.08 4.41 8.67 -2.397 .021
 9. When having to clean a wound or cut on bloody skin.  2.68 4.65 28.82 24.06 -6.455 <.001
10. When going to buy a present or clothing and they offer me something red.  .17 1.39 .74 3.04 -1.125 .267
11. In a party with acquaintances when I have to join the conversation. 2.89 5.11 7.02 9.91 -2.512 .016
12. When I notice the smell and see the dentist’s instruments ready for a dental intervention. 5.65 7.88 25.38 22.05 -5.227 <.001
13. When I feel the needle go into the vein of my arm to extract blood.  8.46 11.37 49.92 23.28 -10.208 <.001
14. When I have to ask for something, make a complaint, or ask a question in public. 8.44 9.48 15.15 16.35 -2.449 .018
15. When I notice an ad about the proper use of hypodermic needles (without considering the possi-
bility of contagion). 
1.14 3.52 11.66 15.28 -4.206 <.001
16. When I think of the color red. .07 .45 .58 2.00 -1.576 .123
17. In a restaurant, when I observe that a piece of meat on the plate is “bloody”. 1.78 4.81 3.71 7.75 -1.480 .146
18. When I see a laboratory tube with blood. 1.34 3.96 20.35 26.19 -4.237 <.001
19. When I see the dentist’s drill going into my mouth. 8.42 9.97 28.17 24.36 -4.749 <.001
20. When I hear a conversation about blood. 1.93 4.97 24.97 23.99 -5.668 <.001
21. When I think that I have to accompany a relative to have a blood test or to cure an open wound. 2.38 4.67 36.12 24.72 -8.061 <.001
22. While I’m in the dentist’s waiting-room. 5.37 8.90 25.17 23.52 -4.990 <.001
23. If I open a meat wrapping and it is smeared with animal blood. .77 2.23 4.15 8.08 -2.298 .027
24. When I have to talk in front of a group of people. 8.78 11.18 16.35 17.62 -2.544 .014
25. When I see another person getting an intramuscular injection. 3.08 5.53 30.02 23.55 -6.933 <.001
26. When I get local anesthesia.  4.97 8.68 33.61 29.04 -5.772 <.001
27. When I see the color red in a picture or poster. .38 2.34 .92 5.76 -0.574 .569
28. When I am in an elevator. 2.54 8.15 4.30 10.24 -0.989 .327
29. When I see a bloody wound or cut. 3.21 5.17 31.43 25.06 -6.606 <.001
30. When I see the dentist before the intervention (mask, gown, gloves). 5.04 8.33 22.35 22.88 -4.522 <.001
31. If I go into the butcher’s shop and I see the butcher with his apron spotted with blood. .40 1.26 4.58 10.90 -2.144 .038
32. When I describe to another person an experience or situation involving blood. 1.43 3.97 14.94 17.11 -4.496 <.001
33. When I think that the nurse has to insert the needle in my vein to extract my blood. 5.80 9.68 42.66 24.31 -8.665 <.001
34. If I see an operation or surgical intervention. 9.22 11.53 43.69 29.34 -6.777 <.001
35. When the dentist’s nurse cleans blood from my mouth with cotton or gauze.  2.15 4.75 20.79 25.64 -4.364 <.001
36. When I think about having to attend a relative (child, parent) to clean or cure a bleeding wound. 3.48 5.65 31.23 25.21 -6.465 <.001
37. When I see a pool of blood on the floor. 3.79 6.32 23.00 25.27 -4.278 <.001
38. When I go into a hospital. 2.93 5.77 23.33 23.37 -5.240 <.001
39. When I think about having to get a blood test.  4.22 8.33 41.07 24.02 -8.973 <.001
40. When I see a TV or newspaper report involving blood.  1.63 3.74 21.76 23.43 -5.225 <.001
41. When I think that, if I go to the emergency ward of a hospital, I may see a stretcher with blood on 
the sheet. 
1.93 4.38 21.05 23.76 -4.738 <.001
42. When I think about having to have local anesthesia for a minor intervention. 4.42 8.44 33.92 25.72 -6.703 <.001
43. When they invite me to eat at a restaurant with other people. 1.48 3.01 5.38 12.18 -1.983 .054
44. When I think that the color dark red looks like blood. .14 .53 1.10 2.78 -2.136 .039
45. When I think that if I go to the dentist for a filling or to get a tooth pulled out, they will have to 
give me an injection in my gum and I will bleed (without considering the possibility of pain).  
3.78 7.38 25.33 24.01 -5.277 <.001
46. When I go to a soccer field or to some public spectacle.  2.18 4.09 4.07 11.53 -1.005 .321
47. When I think of the possibility of donating blood for a relative or friend. 3.84 7.99 38.07 24.82 -8.075 <.001
48. When, after bumping my nose, I think I might get a nosebleed. 1.52 3.62 16.56 22.22 -3.916 <.001
49. When I see a report or documentary film about animals or a bull-fight on TV and I think of the 
possibility of seeing a bleeding animal. 
1.07 2.72 6.15 12.70 -2.367 .023
50. When I get onto a bus or train.  .83 2.63 3.25 9.15 -1.634 .110
 
anales de psicología, 2010, vol. 26, nº 1 (enero) 
62                                                                                                            Mercedes Borda Mas et al. 
Table 2: Symptoms of blood phobia that discriminate between the normal and the blood phobic sample (N = 174). 
Normal  
(n=135) 
Blood phobics 
(n=39) Symptoms (rank: 0-150) M SD M SD 
Value of  
Contrast  
Statistic 
 
p 
Cognitive responses 
(a) I don’t think I will be able to bear the situation. 1.51 2.51 10.87 8.40 -6.867 <.001 
(b) I think that “something bad is going to happen to me.” .56 1.57 5.87 8.35 -3.950 <.001 
(c) My mind goes blank. .66 2.13 4.51 6.88 -.439 <.001 
(d) I perceive that not much time will go by before I get dizzy. .82 1.79 12.589 9.70 -7.539 <.001 
(e) I feel confused, disoriented. 1.42 2.25 9.66 9.80 -5.213 <.001 
(f) I think people will notice how distressed I feel. 1.33 2.72 8.76 9.63 -4.768 <.001 
(g) I don’t think I’ll know how to react. .80 1.94 9.76 9.11 -6.107 <.001 
(h) I remember past experiences and anticipate panic. .86 2.31 11.10 11.03 -5.742 <.001 
(i) I think I’m going to faint. .45 1.47 9.51 9.83 -5.730 <.001 
(j) I must get out of here before I make a fool of myself. .33 1.45 7.87 10.52 -4.461 <.001 
(k) I think I should have avoided the situation, because this feeling is noth-
ing new to me.  
.77 2.23 10.38 9.62 -6.186 <.001 
(l) I think I shall go mad.  .13 .81 1.35 5.03 -1.515 .138 
Physiological responses 
(a) My heartbeat speeds up. 5.46 6.70 26.66 12.58 -10.112 <.001 
(b) My palms or armpits sweat. 3.08 6.29 18.10 15.61 -5.868 <.001 
 (c) My muscles start to tense. 3.04 4.66 11.66 10.34 -5.061 <.001 
(d) I feel that I am getting dizzy. 1.69 3.97 17.89 13.08 -7.629 <.001 
(e) I breathe more quickly.   3.34 5.49 19.58 14.13 -7.027 <.001 
(f) I feel a cold sweat all over my body. 1.57 2.49 9.56 8.94 -5.515 <.001 
(g) I feel more blood pumping in my body.  1.91 3.92 11.82 11.46 -5.310 <.001 
(h) I feel my face is hot. .96 2.12 5.84 7.90 -3.820 <.001 
(i) I lose consciousness.  .11 .61 4.17 6.15 -4.117 <.001 
(j) I get pale. 2.00 4.08 16.76 13.96 -6.524 <.001 
(k) I faint. .28 1.40 7.89 10.43 -4.544 <.001 
(l) I feel a lump in my throat. 2.05 2.83 10.20 9.98 -5.038 <.001 
(m) I feel stomach discomfort. 1.82 3.38 12.10 12.74 -4.989 <.001 
Behavioral responses 
(a) I avoid going. I avoid it. 3.05 4.69 16.64 9.457 -8.671 <.001 
(b) I am paralyzed and cannot move. 1.23 2.74 4.40 4.68 -4.032 <.001 
(c) My legs and/or hands shake.  1.98 3.53 11.92 10.334 -5.906 <.001 
(d) I escape from the situation immediately. 1.55 3.39 12.48 10.417 -6.455 <.001 
(e) I shift around in my seat nervously, etc.  1.37 3.18 12.48 11.341 -6.053 <.001 
(f) My words don’t come out fluidly or my voice is uneven.  1.56 3.97 14.43 14.576 -5.457 <.001 
(g) I keep quiet, speechless. 1.91 3.92 11.82 11.46 -5.310 <.001 
Σ Total responses 69.77 83.91 537.76 349.13 -7.354 <.001 
 
Table 3: Items included in the rotated factor solution of BIPI. 
ComponentsOriginal Situations 
1 2 3 
Final Situations Component
13. When I feel the needle go into the vein of my arm to 
extract blood.  
.800  .425 21(6). When I think that I have to accompany 
a relative to have a blood test or to cure an 
open wound. 
.944 
39. When I think about having to get a blood test. .796  .466 39(14). When I think about having to get a 
blood test. 
.922 
33. When I think that the nurse has to insert the needle in 
my vein to extract my blood. 
.780  .478 33(9). When I think that the nurse has to in-
sert the needle in my vein to extract my 
blood. 
.918 
47. When I think of the possibility of donating blood for a 
relative or friend. 
.776  .460 36(11). When I think about having to attend a 
relative (child, parent) to clean or cure a 
bleeding wound. 
.918 
7. When I get an intravenous injection. .758  .456 25(7). When I see another person getting an 
intramuscular injection. 
.886 
21. When I think that I have to accompany a relative to 
have a blood test or to cure an open wound. 
.742 .434 .403 20(5). When I hear a conversation about 
blood. 
.884 
25. When I see another person getting an intramuscular 
injection. 
.713 .440 .386 34(10). If I see an operation or surgical inter-
vention. 
 
.880 
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42. When I think about having to have local anesthesia for 
a minor intervention.  
.698  .551 41(15). When I think that, if I go to the emer-
gency ward of a hospital, I may see a 
stretcher with blood on the sheet. 
 
.879 
29. When I see a bloody wound or cut. .660 .574 .319 47(17). When I think of the possibility of do-
nating blood for a relative or friend. 
 
.873 
20. When I hear a conversation about blood. .659 .572  37(12). When I see a pool of blood on the 
floor. 
.871 
9. When having to clean a wound or cut on bloody skin. .657 .550 .321 18(4). When I see a laboratory tube with
blood. 
.863 
34. If I see an operation or surgical intervention. .640 .470 .367 7(3). When I get an intravenous injection. .856 
41. When I think that, if I go to the emergency ward of a 
hospital, I may see a stretcher with blood on the sheet. 
.623 .613  42(16). When I think about having to have lo-
cal anesthesia for a minor intervention. 
.851 
36. When I think about having to attend a relative (child, 
parent) to clean or cure a bleeding wound. 
.617 .573 .389 5(2). When I see blood on my arm or finger 
after pricking myself with a needle. 
.847 
5. When I see blood on my arm or finger after pricking 
myself with a needle. 
.609 .435 .420 38(13). When I go into a hospital. .837 
38. When I go into a hospital. .605 .464 .406 48(18). When, after bumping my nose, I think 
might get a nosebleed. 
.822 
23. If I open a meat wrapping and it is smeared with ani-
mal blood. 
 .864  32(8). When I describe to another person an 
experience or situation involving blood. 
.820 
8. If I´m in the kitchen and I see a knife with blood on it 
after cutting meat. 
 .830  2(1). When I see an injured person after an 
accident, bleeding in the road or on TV. 
.750 
31. If I go into the butcher´s shop and I see the butcher 
with his apron spotted with blood. 
 .824  
49. When I see a report or documentary film about ani-
mals or a bull-fight on TV and I think of the possibility 
of seeing a bleeding animal. 
 .820  
32. When I describe to another person an experience or 
situation involving blood. 
.460 .699 .308
37. When I see a pool of blood on the floor. .571 .696  
18. When I see a laboratory tube with blood. .574 .672  
40. When I see a TV or newspaper report involving 
blood. 
.520 .662 .343
48. When, after bumping my nose, I think might get a 
nosebleed. 
.557 .657  
15. When I notice an ad about the proper use of hypo-
dermic needles (without considering the possibility of 
contagion). 
.410 .598 .449
2. When I see an injured person after an accident, bleed-
ing in the road or on TV. 
.491 .532  
4. When going to the dentist for a check-up.   .892
30. When I see the dentist before the intervention (mask, 
gown, gloves). 
.302  .868
6. When I feel discomfort in my mouth and think about 
having to go to the dentist, without considering the 
possibility of pain. 
  .863
19. When I see the dentist´s drill foing into my mouth. .314  .852
22. While I´m in the dentist´s waiting-room. .376  .842
12. When I notice the smell and see the dentist,s instru-
ments ready for a dental intervention. 
 
 
.374
  
 
.838
45. When I think that if I go to the dentist for a filling or 
to get a tooth pulled out, the will have to give me an in-
jection in my gum and I will bleed (without considering 
the possibility of pain). 
.423  .804
26. When I get local anesthesia. .619  .648
35. When the dentist´s nurse cleans blood from my 
mouth with cotton or gauze. 
.426 .507 .575
Note: ( ) Number that appear in the proposed version 
Note. Extraction method: principal component analysis, rotation method: Varimax normalization with Kaiser, the rotation converged at 6 iterations. 
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The adequacy of factor analysis was assessed by three 
indexes: KMO (.94), the determinant of the correlation ma-
trix (2.56×10-13), and Bartlett's sphericity test, χ2 (153) = 
4933.8, p < .001. All of them yielded values that indicated 
that factor analysis was appropriate. 
 As the first factor explained 69% of the variance, a suffi-
cient quantity to consider the instrument one-dimensional, 
we carried out a one-dimensional factor analysis with the 36 
situations that are displayed in Table 3. For the fit of the 
factor solution, we used the following indexes: the non-
normed fit index (NNFI, Bentler & Bonnett, 1980), the 
comparative fit index (CFI, Bentler, 1989), the value of the 
goodness-of-fit index (GFI), and the adjusted goodness of 
fit index (AGFI), Kelly’s criterion (Lorenzo-Seva & Fer-
rando, 2006), and the root mean square of residuals (RMSR, 
Bentler, 1995). The model was considered acceptable if it 
met the criteria RMSR < .08 (Hu & Bentler, 1999); GFI, 
AGFI, CFI, and NNFI > .90. 
In addition to the former global fit indexes, we refined 
the instrument, progressively eliminating the situations 
whose standardized residuals were beyond the range (-2.58, 
2.58). The standardized residuals refer to the differences 
between the observed correlations and those estimated by 
the factor solution. After applying this latter criterion, 18 
situations remained, which are shown in Appendix 2. 
 As seen in Table 3, which shows the one-dimensional 
model, the goodness-of-fit indexes indicate that the fit of the 
model was adequate, χ2 (135) = 1230.45, p <.001; GFI = .99, 
AGFI = .99, CFI = .77, NNFI = .74, Kelly’ criterion = .075; 
RMSR = .059. The range of smallest and largest standard-
ized residual was (-1.38, 1.96). There are 18 situations that 
constitute a single factor of “blood phobia” that explained 
76% of the variance (see Table 3). 
 
Factor analysis of the cognitive, physiological, and 
behavioral responses of the BIPI. 
 
Exploratory factor analysis with principal components 
and varimax rotation was applied to the 31 sypmtoms result-
ing from applying the above-mentioned criterion. We used 
Kaiser’s criterion (eigenvalues higher than 1) to retain fac-
tors and we selected only the items with loadings >.50 (see 
Table 4). We eliminated 4 symptoms with this criterion: 1 of 
the 12 cognitive responses (C symptoms “My mind goes 
blank”), 1 of the 13 physiological symptoms (I “I lose con-
sciousness”), and 2 of the 7 behavioral symptoms (B “I am 
paralyzed and cannot move” and G “I keep quiet, speechless”). 
 
The adequacy of the factor analysis was assessed with 
three indexes: KMO (.94), the determinant of the correlation 
matrix (1.10-14), and Bartlett's sphericity test, χ2 (351) = 
7294.9, p < .001. All of them yielded values that indicated 
that factor analysis was appropriate. 
 As the first factor explained 74% of the variance, a suffi-
cient quantity to consider the instrument one-dimensional, 
we carried out a one-dimensional factor analysis with the 27 
symptoms that are displayed in Table 4. For the fit of the 
factor solution, we used the same indexes as those of the 
factor analysis of the situations. 
 In Table 4, which shows the one-dimensional model, the 
goodness of fit indexes indicate that the fit of the model was 
adequate, χ2 (324) = 2061.33, p <.001; GFI = 1.00, AGFI = 
1.00, CFI = .75, NNFI = .73, Kelly’ criterion = .076, RMSR 
= .049. The range of smallest and largest standardized resid-
ual was (-1.62, 2.14). There are 27 symptoms that constitute 
a single factor of “symptoms in blood phobia” that ex-
plained 74% of the variance. 
The BIPI is a self-report made up of 18 items or situa-
tions related to blood. The content of the items meets the 
diagnostic criteria of the DSM-IV (APA, 1994), and is 
adapted to the modifications introduced in the DSM-IV-R 
(APA, 2000); specifically, blood, injections, and injuries. It 
includes an array of symptoms corresponding to the cogni-
tive, physiological, and behavioral responses, with a total of 
27 anxiety symptoms (see Appendix 2). 
 It is presented in a self-report format. In each situation, 
the person should indicate the frequency with which each 
one of the responses occurs. Each item is rated on a 4-point 
Likert-type scale, ranging from 0 (never) to 3 (always). The 
rating of 0 represents the absence of the response or symp-
tom that is being assessed and 3 corresponds to the maxi-
mum occurrence. Total score was obtained by adding scores 
in each of the 27 symptoms. The normal participants’ mean 
score was 69.97 (SD = 83.91), and in the blood phobics, it 
was 537.76 (SD = 349.13), t(172) = -8.30, p <.001. 
 
Psychometric properties 
 
Reliability 
 
The internal consistency index of the inventory, obtained 
with Cronbach's alpha coefficient, was .98 in the total sam-
ple of participants (normal and blood phobics, N = 174), for 
both the symptoms and the situations. The reliability or in-
ternal homogeneity coefficient, obtained by means of the 
method of Guttman’s split halves with the entire sample of 
participants, was .98, and the Pearson coefficient between 
both halves was .96.  
 
Validity  
 
The convergent validity among response types, assessed 
by the correlation both in the sample of normal participants 
and in the blood phobics, indicates that the cognitive, 
physiological, and behavioral responses are significantly as-
sociated with each other in the measurements of the BIPI 
and that this association is higher in the sample of blood 
phobics (see Table 5). 
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Table 4: Symptoms included in the rotated factor solution of BIPI. 
Original Symptoms Compo- 
nents 
Final Symptoms Compo- 
nent 
I don´t think I´ll know to react. .933 I don´t think I´ll know to react. .933 
I perceive that not much time will go by before I get 
dizzy. 
.930 I perceive that not much time will go by before I get 
dizzy 
.929 
I think I´m going to faint. .928 I think I´m going to faint. .928 
I don´t think I will be able to bear the situation. .924 I don´t think I will be able to bear the situation. .924 
I breathe more quickly. .918 I breathe more quickly. .917 
I think I should have avoided the situation, because this 
feeling is nothing new to me. 
.917 I think I should have avoided the situation, because this 
feeling is nothing new to me. 
.915 
I escape from the situation immediately. .895 I escape from the situation immediately. .894 
I shift around in my seat nervously, etc. .891 I shift around in my seat nervously, etc. .890 
I must get out of here before I make a fool of myself. .887 I must get out of here before I make a fool of myself .886 
I get pale. .886 I get pale. .885 
I feel that I am getting dizzy. .885 I feel that I am getting dizzy. .885 
My legs and/or hands shake. .871 My legs and/or hands shake. .871 
I think people will notice how distressed I feel. .860 I think people will notice how distressed I feel. .859 
My words don´t come out fluidly or my voice is uneven. .856 My words don´t come out fluidly or my voice is un-
even. 
.857 
My hearbeat speeds up. .855 My hearbeat speeds up. .854 
I feel a cold sweat all over my body. .852 I feel a cold sweat all over my body. .852 
I avoid going. I avoid it. .852 I avoid going. I avoid it. .850 
I remember past experiences and anticipate panic. .847 I feel confused, disoriented. .847 
I feel confused, disoriented. .845 I remember past experiences and anticipate panic. .846 
I fant. .838 I fant. .840 
My palms or armpits sweat. .835 My palms or armpits sweat. .834 
I feel a lump in my throat. .822 I feel a lump in my throat. .822 
I think that “something bad is going to happen to me”. .804 I think that “something bad is going to happen to me”. .808 
My muscles start to tense. .795 My muscles start to tense. .793 
I feel stomach discomfort. .782 I feel stomach discomfort. .781 
I lose consciousness. .774 I feel more blood pumping in my body. .690 
I feel my face is hot. .694 I feel my face is hot. .690 
I keep quiet, speechless. .688 
I feel more blood pumping in my body. .688 
My mind goes blank. .621 
I am paralyzed and cannot move. .523 
Note.- Extraction method: principal component analysis, rotation method: Varimax normalization with Kaiser. 
 
Table 5: Pearson correlation coefficients among the different types of cog-
nitive, physiological, and behavioral responses and the total BIPI score  
Responses Total 
(N=174) 
r 
Normal 
(n=135) 
r 
Blood phobics
(n=39) 
r 
Cognitive-Physiological .94** 
p <.001 
.87** 
p <.001 
.94** 
p <.001 
Physiological-Behavioral .85** 
p <.001 
.44** 
p <.001 
.90** 
p <.001 
Behavioral-Cognitive .84** 
p <.001 
.48 
p = 138 
.91** 
p <.001 
 
 Convergent validity with other instruments, assessed 
with the subscale of blood phobia of the FQ (Marks & 
Mathews, 1979) and the three response types of the BIPI 
obtained from the sample of blood phobic participants, in-
dicates a significant correlation between the cognitive re-
sponses (r = .59, p < .001), the physiological responses (r = 
.56, p < .001), and the behavioral responses (r = .55, p < 
.001) with the blood phobia subscale of the FQ, respectively. 
 Sensitivity to change, appraised by comparative analysis 
of the responses given by the sample of the 39 blood phobic 
participants before and after the treatment, indicates that the 
BIPI discriminates between pre and post-treatment re-
sponses and therefore serves to detect therapeutic change in 
blood phobia, t(37) = 8.45, p = .001 (M pret = 536.76, SD = 
347.13; M post = 137.28, SD = 173.80). 
 Discriminant validity, obtained using the agoraphobia 
subscale and the fear subscale of the social situations of the 
FQ (Marks & Mathews, 1979) shows nonsignificant correla-
tions, indicating that the BIPI measures a different construct 
from agoraphobia and/or social anxiety. 
 
Diagnostic efficacy of the BIPI  
 
The diverse dimensions of the self-report discriminate 
well between the normal and the blood phobic samples. In 
fact, it correctly classified 92.5% of the participants, so the 
value of the diagnostic efficacy of the BIPI is high. More-
over, it has a specificity of 97.1%, and a sensitivity of 76.9% 
(see Table 6). The proposed cut-off point for the global in-
ventory, corresponding to percentile 75 in the normal sam-
ple, is 95 points.  
anales de psicología, 2010, vol. 26, nº 1 (enero) 
66                                                                                                            Mercedes Borda Mas et al. 
Table 6: Diagnostic efficacy of the BIPI (N = 174). 
 Predicted groups 
Observed groups Normal Blood  
phobics 
TOTAL 
Normal 131 
(97.1%) 
4 (2.9%) 135 
Blood phobics 9 (23.1%) 30 (76.9%) 39 
Sensitivity True positives /total patients x 100 = 
30 / 39 x 100 = 76.92 
Specificity 100- False positives /total normals x 
100 = 100 – 4 /135 x 100 = 97.10 
Diagnostic efficacy Total correctly classified /total global x 
100 = 161 / 174 x 100 = 92.52 
 
Discussion 
 
Diverse instruments have been used in studies of the effi-
cacy of the assessment and psychological treatment of blood 
phobia. The first questionnaires elaborated, such as the FQ 
and the FSS-III, are general, and measure a limited number 
of contexts associated with fears and phobias. Other instru-
ments focus on identifying specific situations related to 
blood (MQ, MFS, MAS, and BISS). Whereas these assess-
ment measurements do not reflect the totality of blood pho-
bia, the MBPI is a multidimensional inventory that assesses 
four types of stimuli (injections, hospitals, blood, and inju-
ries) and the presence of five kinds of response (fear, avoid-
ance, worry, distress, and fainting). The BIPI, a self-report 
measure with similar characteristics to the MBPI, was elabo-
rated to assess the severity of phobic symptoms in certain 
contexts or when facing situations involving blood, injec-
tions, and injuries. 
 The first goal of this study is to explore the psychometric 
characteristics of the BIPI. As mentioned, in order to vali-
date the instrument, we used participants from the general 
population residing in the Region of Andalusia (Spain). It is, 
therefore, the first inventory elaborated in the Spanish lan-
guage and adapted to the Spanish population. 
 The results revealed that it has excellent reliability and 
internal consistency, as well as good convergent validity with 
the subscale of blood phobia of the FQ (Marks & Mathews, 
1979), the most frequently used inventory. The BIPI dis-
criminates individuals who meet the criterion of specific 
phobia, subtype blood/injury phobia, from individuals with 
other types of fears such as social phobia and agoraphobia. 
It does not correlate significantly with these FQ subscales, 
thus indicating that blood phobia is a measure of a specific 
fear with different characteristics from other phobias. More-
over, it presents adequate sensitivity, good specificity, and 
diagnostic efficacy. It discriminates satisfactorily between 
blood phobics/nonphobics.  
 The second goal was to determine, by exploratory facto-
rial analysis, whether blood phobia is a one-dimensional 
construct. The single factor, extracted with principal com-
ponent analysis, for situations and phobic symptoms ex-
plained 76% and 74% of the variance, respectively. These 
results suggest that blood phobia is a unitary psychometric 
construct and that it adequately taps a broad array of phobic 
contexts and symptoms that configure the severity of the 
specific phobia in individuals with blood phobia. 
 The good convergent validity of the responses indicates 
that the inventory is a one-dimensional measurement of this 
subtype of phobia that satisfactorily assesses blood phobia. 
In contrast, most of the other instruments, such as, for ex-
ample, the MBPI, are multidimensional. In this case, the first 
factor -blood phobia- of the six factors yielded by the factor 
solution explained 42.5% of the total variance (Wenzel & 
Holt, 2003). 
 In contrast to other instruments, the inventory integrates 
symptoms proceeding from the three response types (cogni-
tive, physiological, and behavioral). It reflects the most no-
table characteristic of blood phobia, the predisposition to 
vasovagal syncope, which is a biphasic physiological re-
sponse in this phobia. It identifies individuals with fainting 
episodes and the relation of such episodes with the rest of 
the symptoms of the vasovagal syncope. Various investiga-
tors have offered diverse explanations of this dysfunction in 
the last few years (Accurso et al, 2001; Gerlach et al., 2006). 
 Two relevant characteristics that are derived from the 
BIPI are that it separates phobic symptoms involving one’s 
own blood from that of other people’s blood. Moreover, it 
also distinguishes the individual’s cognitive, physiological, 
and behavioral symptoms in phobic contexts and the cogni-
tive, physiological, and behavioral symptoms when anticipat-
ing future exposure to phobic stimuli. In other words, it 
allows the appraisal of the severity of the 27 symptoms in 
the 18 phobic contexts. Despite that the factor analysis sug-
gests that blood phobia is a unitary phenomenon (Borda, 
2001), the variability of the clinical profiles indicates that it 
would be very useful to assess the particular profile of each 
person for successful treatment. 
 Lastly, the third goal of the study was to determine 
whether it is an efficacious tool to detect therapeutic im-
provement in blood phobics. The BIPI is sensitive to thera-
peutic change, as it discriminates between responses before 
and after treatment in people diagnosed with blood phobia. 
Of the 39 patients who were treated with in vivo exposure, 
19 were also trained in the technique of applied tension. 
After treatment, the BIPI scores indicated a notable change 
in the severity of the blood phobia. The improvement was 
detected by the self-report (Borda et al., 1997; Borda et al, 
1998). 
 In conclusion, as noted by Marks & Mathews (1979), a 
valid instrument to assess treatment success should ade-
quately measure the globality of the specific characteristics 
of the clinical samples with this subtype of phobia. In this 
sense, the BIPI meets this need satisfactorily. It responds to 
an unidimensional construct and it integrates the current 
phobic behaviors, the physical symptoms, and the thoughts 
present in blood-related contexts. 
 As limitations of the study included the age range of the 
composition of the sample, with a predominance of women, 
in order to generalization of the results. 
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Appendix 1: Development of the 50 preliminary situations and measurement of each item . 
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 1. When I walk along the beach or in the mountains        X  
(*) 2. When I see an injured person after an accident, bleeding in the road or on TV. X         
 3. In a group of friends or coworkers, when they ask my opinion.         X
 4. When going to the dentist for a check-up.     X     
(*) 5. When I see blood on my arm or finger after pricking myself with a needle. X  X       
 6. When I feel discomfort in my mouth and think about having to go to the dentist, without considering the possibility 
of pain. 
     X    
(*) 7. When I get an intravenous injection.   X       
 8. If I’m in the kitchen and I see a knife with blood on it after cutting meat.       X   
 9. When having to clean a wound or cut on bloody skin. X         
10. When going to buy a present or clothing and they offer me something red.        X   
11. In a party with acquaintances when I have to join the conversation.         X
12. When I notice the smell and see the dentist’s instruments ready for a dental intervention.     X     
13. When I feel the needle go into the vein of my arm to extract blood. X  X       
14. When I have to ask for something, make a complaint, or ask a question in public.         X
15. When I notice an ad about the proper use of hypodermic needles (without considering the possibility of contagion).   X       
16. When I think of the color red.        X   
17. In a restaurant, when I observe that a piece of meat on the plate is “bloody”.       X   
(*) 18. When I see a laboratory tube with blood. X         
19. When I see the dentist’s drill going into my mouth.     X     
(*) 20. When I hear a conversation about blood. X         
(*) 21. When I think that I have to accompany a relative to have a blood test or to cure an open wound.  X        
22. While I’m in the dentist’s waiting-room.     X     
23. If I open a meat wrapping and it is smeared with animal blood.       X   
24. When I have to talk in front of a group of people.         X
(*) 25. When I see another person getting an intramuscular injection.   X       
26. When I get local anesthesia.   X       
27. When I see the color red in a picture or poster.        X   
28. When I am in an elevator.        X  
29. When I see a bloody wound or cut. X         
30. When I see the dentist before the intervention (mask, gown, gloves).     X     
31. If I go into the butcher’s shop and I see the butcher with his apron spotted with blood.       X   
(*) 32. When I describe to another person an experience or situation involving blood. X         
(*) 33. When I think that the nurse has to insert the needle in my vein to extract my blood.  X  X      
(*) 34. If I see an operation or surgical intervention. X         
35. When the dentist’s nurse cleans blood from my mouth with cotton or gauze. X    X     
(*) 36. When I think about having to attend a relative (child, parent) to clean or cure a bleeding wound.  X        
(*) 37. When I see a pool of blood on the floor. X         
(*) 38. When I go into a hospital.        X  
(*) 39. When I think about having to get a blood test.  X        
40. When I see a TV or newspaper report involving blood. X         
(*) 41. When I think that, if I go to the emergency ward of a hospital, I may see a stretcher with blood on the sheet.  X        
(*) 42. When I think about having to have local anesthesia for a minor intervention.    X      
43. When they invite me to eat at a restaurant with other people.         X
44. When I think that the color dark red looks like blood.        X   
45. When I think that if I go to the dentist for a filling or to get a tooth pulled out, they will have to give me an injec-
tion in my gum and I will bleed (without considering the possibility of pain). 
 X  X  X    
46. When I go to a soccer field or to some public spectacle.        X  
(*) 47. When I think of the possibility of donating blood for a relative or friend.  X  X      
(*) 48. When, after bumping my nose, I think I might get a nosebleed.  X        
49. When I see a report or documentary film about animals or a bull-fight on TV and I think of the possibility of seeing 
a bleeding animal. 
 X     X   
50. When I get onto a bus or train.        X  
(1) Situational anxiety 
(2) Anticipatory anxiety 
(*) Situations that appear in the proposed version 
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Appendix 2: Items of the proposed version of the BIPI 
 
In next page you have a list of situations where you can find yourself and that could create distress, tension, etc. to you. 
The objective is to evaluate the different reactions that occur to you in each of the described situations. 
 
The task is to rate from 0 to 3, the frequency of each symptom. Use the following scale: 
3 = Always 
2 = Almost always 
1 = Sometimes 
0 = Never 
 
The procedure is the following: Read each of the situations shown on the left side, and then score from 0 to 3 each symp-
tom that is listed in the top of the page. 
 
 
 
 
Apéndice 2: Items en la versión definitiva del BIPI 
 
 A continuación, se le presenta un listado de situaciones en las que Vd puede encontrarse y que podrían suscitarle malestar, 
tensión, etc. El objetivo es valorar las diferentes reacciones que se producen en Vd. ante cada una de las situaciones expuestas.  
 La tarea consiste en puntuar de 0 a 3 la frecuencia de cada uno de los síntomas. Utilice la siguiente escala: 
   3 =Siempre 
   2 =Casi siempre 
   1 =A veces 
   0 =Nunca 
 El procedimiento a seguir es el siguiente: Lea cada una de las situaciones que aparecen en la parte izquierda y, a continuación, 
puntúe de 0 a 3 cada síntoma que se indica en la parte superior de la página.  
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